T. Rowe Price Associates
TRHC

T. Rowe Price Associates’s Tabula Rasa HealthCare, Inc. Common Stock TRHC Stock Holding History

T. Rowe Price Associates’s Portfolio TRHC Stock Details TRHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-8,825
Closed -$231K – 3058
2021
Q3 		$231K Hold
8,825
– – ﹤0.01% 2672
2021
Q2 		$441K Buy
8,825
+509
+6% +$22.8K ﹤0.01% 2440
2021
Q1 		$383K Sell
8,316
-123,951
-94% -$5.92M ﹤0.01% 2482
2020
Q4 		$5.67M Sell
132,267
-62,478
-32% -$2.37M ﹤0.01% 1427
2020
Q3 		$7.94M Sell
194,745
-364,219
-65% -$18.1M ﹤0.01% 1345
2020
Q2 		$30.6M Sell
558,964
-30,770
-5% -$1.76M ﹤0.01% 1006
2020
Q1 		$30.8M Sell
589,734
-183,400
-24% -$9.93M ﹤0.01% 936
2019
Q4 		$37.6M Sell
773,134
-573,036
-43% -$26.8M ﹤0.01% 1002
2019
Q3 		$74M Buy
1,346,170
+30,954
+2% +$1.77M 0.01% 723
2019
Q2 		$65.7M Buy
1,315,216
+202,683
+18% +$10.1M 0.01% 785
2019
Q1 		$62.8M Buy
1,112,533
+830,058
+294% +$49.5M 0.01% 783
2018
Q4 		$18M Buy
282,475
+16,767
+6% +$1.19M ﹤0.01% 1178
2018
Q3 		$21.6M Buy
265,708
+106,323
+67% +$7.79M ﹤0.01% 1205
2018
Q2 		$10.2M Buy
+159,385
New +$7.82M ﹤0.01% 1339

Other funds holding TRHC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CS
Cannell & Spears New York $5.62B AUM 41.25% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
LOAMS
Lombard Odier Asset Management (Switzerland) Petit-Lancy, Switzerland $3.14B AUM 46.44% 1-Year Est. Return

T. Rowe Price Associates's TRHC Position: Q4 2021 in Review

T. Rowe Price Associates sold out of Tabula Rasa HealthCare, Inc. Common Stock (TRHC) in Q4 2021, closing a stake of 8,825 shares — an estimated $231K sold.

T. Rowe Price Associates first reported a position in TRHC in Q2 2018 and held it in 14 quarters. The position peaked at $74M in Q3 2019. 138 funds tracked by Wall St. Rank hold TRHC as of Q4 2021.

  • T. Rowe Price Associates reported no remaining Tabula Rasa HealthCare, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • T. Rowe Price Associates sold 8,825 Tabula Rasa HealthCare, Inc. Common Stock shares in Q4 2021, an estimated $231K.
  • T. Rowe Price Associates first reported a position in Tabula Rasa HealthCare, Inc. Common Stock in Q2 2018 and held it in 14 quarters.
  • T. Rowe Price Associates's Tabula Rasa HealthCare, Inc. Common Stock position peaked at $74M in Q3 2019.
  • 138 funds tracked by Wall St. Rank held Tabula Rasa HealthCare, Inc. Common Stock as of Q4 2021.

Based on T. Rowe Price Associates's 13F filing for Q4 2021, filed 14 Feb 2022.